Abstract
This paper discusses quantum mechanical schemas for describing waves with non-abelian phases, Fock spaces of annihilation-creation operators for these structures, and the Feynman recipe for obtaining descriptions of particle interactions with external fields applied to predicted chemo-polypharmacophoric agent on Hypercomplex Extensions of a Quantum Theory Bayesian parameter estimation for nonlinear modelling of biological pathways comprising (Propeptide-Fc)/MGF peptide mimicking high free binding energy properties towards Wnt7a/Fzd7 signalling Akt/mTOR anabolic growth IGF-I/PI3K/Akt -I/MAPK/ERK pathways.
Keywords
Hypercomplex Extensions; Quantum Theory; Bayesian parameter estimation; nonlinear modelling; biological pathways; chemo-polypharmacophoric agent; (Propeptide-Fc)/MGF; peptide mimicking; high free binding energy; properties towards Wnt7a/Fzd7 signalling; Akt/mTOR anabolic growth; IGF-I/PI3K/Akt -I/MAPK/ERK pathways; Composition Algebras, Hilbert Spaces, Fock Spaces, Non-Abelian Gauge Fields
Article Type
Research Article - Abstract
Publication history
Received: Sep 20, 2017
Accepted: Sep 25, 2017
Published: Oct 01, 2017
Citation
Grigoriadis Ioannis, Grigoriadis George, Grigoriadis Nikolaos, George Galazios (2017) A predicted chemo-polypharmacophoric agent on Hypercomplex Extensions of a Quantum Theory Bayesian parameter estimation for nonlinear modelling of biological pathways comprising (Propeptide-Fc)/MGF peptide mimicking high free binding energy properties towards Wnt7a/Fzd7 signalling Akt/mTOR anabolic growth IGF-I/PI3K/Akt -I/MAPK/ERK pathways.
Authors Info
Grigoriadis Nikolaos
Department of IT Computer Aided Personalized Myoncotherapy, Cartigenea-Cardiogenea, Neurogenea-Cellgenea, Cordigenea-HyperoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;
Grigoriadis Ioannis
Department of Computer Drug Discovery Science, BiogenetoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;
Grigoriadis George
Department of Stem Cell Bank and ViroGeneaTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;
George Galazios
Professor of Obstetrics and Gynecology,
Democritus University of Thrace,
Komotini, Greece;
E-mail: biogeneadrug@gmail.com